Rite Aid Corporation (NYSE: RAD) Stock Competitors & Peer Comparison

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, RPRX has a market cap of 27B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while RPRX trades at $60.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas RPRX's P/E ratio is 11.59. In terms of profitability, RAD's ROE is +2.76%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, RAD is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check RPRX's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, CORT has a market cap of 12.3B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CORT trades at $113.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas CORT's P/E ratio is 325.37. In terms of profitability, RAD's ROE is +2.76%, compared to CORT's ROE of +0.08%. Regarding short-term risk, RAD is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CORT's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while WBA trades at $11.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas WBA's P/E ratio is -1.64. In terms of profitability, RAD's ROE is +2.76%, compared to WBA's ROE of -0.42%. Regarding short-term risk, RAD is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for RAD.Check WBA's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, KNSA has a market cap of 6.1B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while KNSA trades at $78.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas KNSA's P/E ratio is 88.67. In terms of profitability, RAD's ROE is +2.76%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, RAD is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for RAD.Check KNSA's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, LQDA has a market cap of 6B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while LQDA trades at $67.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas LQDA's P/E ratio is 483.50. In terms of profitability, RAD's ROE is +2.76%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, RAD is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for RAD.Check LQDA's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, PBH has a market cap of 2.5B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while PBH trades at $52.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas PBH's P/E ratio is 11.87. In terms of profitability, RAD's ROE is +2.76%, compared to PBH's ROE of +0.09%. Regarding short-term risk, RAD is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for RAD.Check PBH's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, LTGO has a market cap of 1.5B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while LTGO trades at $24.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas LTGO's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to LTGO's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to LTGO. This indicates higher risk in terms of short-term price fluctuations for RAD.Check LTGO's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while HROWL trades at $25.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas HROWL's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, RAD is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for RAD.Check HROWL's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while HROWM trades at $26.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas HROWM's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, RAD is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for RAD.Check HROWM's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, HELP has a market cap of 755M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while HELP trades at $12.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas HELP's P/E ratio is -2.92. In terms of profitability, RAD's ROE is +2.76%, compared to HELP's ROE of -0.71%. Regarding short-term risk, RAD is more volatile compared to HELP. This indicates higher risk in terms of short-term price fluctuations for RAD.Check HELP's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SVA trades at $6.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas SVA's P/E ratio is -5.68. In terms of profitability, RAD's ROE is +2.76%, compared to SVA's ROE of -0.01%. Regarding short-term risk, RAD is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for RAD.Check SVA's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, CUVL has a market cap of 310.6M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CUVL trades at $6.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas CUVL's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to CUVL's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CUVL's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, CELG-RI has a market cap of 244.7M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CELG-RI trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to CELG-RI's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CELG-RI's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, HITI has a market cap of 220.6M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while HITI trades at $2.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas HITI's P/E ratio is -7.36. In terms of profitability, RAD's ROE is +2.76%, compared to HITI's ROE of -0.43%. Regarding short-term risk, RAD is more volatile compared to HITI. This indicates higher risk in terms of short-term price fluctuations for RAD.Check HITI's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, ATLN has a market cap of 73.2M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while ATLN trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas ATLN's P/E ratio is -0.68. In terms of profitability, RAD's ROE is +2.76%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, RAD is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for RAD.Check ATLN's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, CTOR has a market cap of 72.1M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CTOR trades at $0.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas CTOR's P/E ratio is -1.65. In terms of profitability, RAD's ROE is +2.76%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, RAD is more volatile compared to CTOR. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CTOR's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, SDEV has a market cap of 47.8M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SDEV trades at $0.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas SDEV's P/E ratio is -0.17. In terms of profitability, RAD's ROE is +2.76%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, RAD is more volatile compared to SDEV. This indicates higher risk in terms of short-term price fluctuations for RAD.Check SDEV's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, NSRX has a market cap of 34.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while NSRX trades at $4.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas NSRX's P/E ratio is -5.62. In terms of profitability, RAD's ROE is +2.76%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, RAD is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check NSRX's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while GLTO trades at $21.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas GLTO's P/E ratio is -1.78. In terms of profitability, RAD's ROE is +2.76%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, RAD is more volatile compared to GLTO. This indicates higher risk in terms of short-term price fluctuations for RAD.Check GLTO's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, SCYX has a market cap of 34M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SCYX trades at $5.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas SCYX's P/E ratio is -1.58. In terms of profitability, RAD's ROE is +2.76%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, RAD is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check SCYX's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, CNSY has a market cap of 21M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CNSY trades at $3.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas CNSY's P/E ratio is -0.42. In terms of profitability, RAD's ROE is +2.76%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, RAD is more volatile compared to CNSY. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CNSY's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, BFRI has a market cap of 20.4M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while BFRI trades at $1.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas BFRI's P/E ratio is -2.89. In terms of profitability, RAD's ROE is +2.76%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, RAD is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for RAD.Check BFRI's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, SCNX has a market cap of 16M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SCNX trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas SCNX's P/E ratio is -0.16. In terms of profitability, RAD's ROE is +2.76%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, RAD is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check SCNX's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, BFRIW has a market cap of 14.2M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while BFRIW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas BFRIW's P/E ratio is -0.02. In terms of profitability, RAD's ROE is +2.76%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, RAD is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for RAD.Check BFRIW's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, COSM has a market cap of 12.2M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while COSM trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas COSM's P/E ratio is -0.30. In terms of profitability, RAD's ROE is +2.76%, compared to COSM's ROE of -1.19%. Regarding short-term risk, RAD is more volatile compared to COSM. This indicates higher risk in terms of short-term price fluctuations for RAD.Check COSM's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CJJD trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas CJJD's P/E ratio is -0.46. In terms of profitability, RAD's ROE is +2.76%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, RAD is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CJJD's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SSY trades at $1.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas SSY's P/E ratio is -2.86. In terms of profitability, RAD's ROE is +2.76%, compared to SSY's ROE of -0.09%. Regarding short-term risk, RAD is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for RAD.Check SSY's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, POM has a market cap of 6.4M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while POM trades at $0.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas POM's P/E ratio is -0.19. In terms of profitability, RAD's ROE is +2.76%, compared to POM's ROE of +0.16%. Regarding short-term risk, RAD is more volatile compared to POM. This indicates higher risk in terms of short-term price fluctuations for RAD.Check POM's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, BGMS has a market cap of 4.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while BGMS trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas BGMS's P/E ratio is -0.25. In terms of profitability, RAD's ROE is +2.76%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, RAD is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for RAD.Check BGMS's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, PAVS has a market cap of 4.1M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while PAVS trades at $4.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas PAVS's P/E ratio is -0.05. In terms of profitability, RAD's ROE is +2.76%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, RAD is more volatile compared to PAVS. This indicates higher risk in terms of short-term price fluctuations for RAD.Check PAVS's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while MDVL trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas MDVL's P/E ratio is -0.05. In terms of profitability, RAD's ROE is +2.76%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, RAD is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for RAD.Check MDVL's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while ATNFW trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas ATNFW's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, RAD is more volatile compared to ATNFW. This indicates higher risk in terms of short-term price fluctuations for RAD.Check ATNFW's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while BGMSP trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, RAD's ROE is +2.76%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, RAD is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for RAD.Check BGMSP's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while AZNH trades at $53.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas AZNH's P/E ratio is 38.35. In terms of profitability, RAD's ROE is +2.76%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, RAD is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for RAD.Check AZNH's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while LFLYW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, RAD's ROE is +2.76%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, RAD is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for RAD.Check LFLYW's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, PRPH has a market cap of 295.7K. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while PRPH trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas PRPH's P/E ratio is -0.01. In terms of profitability, RAD's ROE is +2.76%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, RAD is more volatile compared to PRPH. This indicates higher risk in terms of short-term price fluctuations for RAD.Check PRPH's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, CPD has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CPD trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas CPD's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to CPD's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CPD's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, POZN has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while POZN trades at $5.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas POZN's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to POZN's ROE of +0.61%. Regarding short-term risk, RAD is more volatile compared to POZN. This indicates higher risk in terms of short-term price fluctuations for RAD.Check POZN's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while ESRX trades at $92.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas ESRX's P/E ratio is 10.69. In terms of profitability, RAD's ROE is +2.76%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, RAD is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check ESRX's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, OREX has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while OREX trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas OREX's P/E ratio is -0.14. In terms of profitability, RAD's ROE is +2.76%, compared to OREX's ROE of -0.54%. Regarding short-term risk, RAD is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for RAD.Check OREX's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SHPG trades at $179.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas SHPG's P/E ratio is 11.35. In terms of profitability, RAD's ROE is +2.76%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, RAD is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for RAD.Check SHPG's competition here

Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAD stands at 36.8M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while IPXL trades at $18.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAD currently has a P/E ratio of -0.05, whereas IPXL's P/E ratio is -10.11. In terms of profitability, RAD's ROE is +2.76%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, RAD is more volatile compared to IPXL. This indicates higher risk in terms of short-term price fluctuations for RAD.Check IPXL's competition here